Comín Colet, Josep
Josep Comín-Colet researcher ORCID ID = 0000-0001-8780-720X
VIAF ID: 304364095 ( Personal )
Permalink: http://viaf.org/viaf/304364095
Preferred Forms
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Aspectos emergentes en la fisiopatología del hierro en insuficiencia cardiaca crónica: implicaciones clínicas, pronósticas y asociación con la activación neurohormonal |
|
| Associations between self-reported periodontal disease, assessed using a very short questionnaire, cardiovascular disease events and all-cause mortality in a contemporary multi-ethnic population: The Multi-Ethnic Study of Atherosclerosis (MESA) |
|
| Avances en el tratamiento neurohormonal de la insuficiencia cardiaca : bloqueo selectivo de la aldosterona : experiencias clínicas con eplerenona |
|
| Clinical predictors of outcome in patients with heart failure and neurohormonal blockade: referral for transplantation from heart failure units without heart transplantation programs |
|
| Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. |
|
| Current situation of management of systolic heart failure in Spain: VIDA-IC study results |
|
| Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation |
|
| Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction. |
|
| The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. |
|
| Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients. |
|
| Explicit and implicit emotional expression in bulimia nervosa in the acute state and after recovery. |
|
| Impacto del déficit de hierro en los síntomas, capacidad funcional y calidad de vida relacionada con la salud en pacientes con insuficiencia cardiaca crónica : nuevas evidencias |
|
| La Insuficiencia cardíaca : guía práctica para el paciente y su entorno |
|
| Nous reptes en la insuficiència cardíaca crònica comorbiditats emergents i objectius centrats en el pacient |
|
| Performance of Comprehensive Risk Adjustment for the Prediction of In-Hospital Events Using Administrative Healthcare Data: The Queralt Indices |
|
| A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure : an expert panel consensus |
|
| Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis. |
|
| Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care. |
|
| Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia |
|
| Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period |
|
| Repetitive use of levosimendan in advanced heart failure need for stronger evidence in a field in dire need of a useful therapy |
|
| [Severe digoxin poisoning. The successful use of the classic treatment] |
|
| Short-Term therapies for treatment of acute and advanced heart failure-why so few drugs available in clinical use, why even fewer in the pipeline? |
|
| Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS) |
|
| Survival in Mediterranean ambulatory patients with chronic heart failure. A population-based study. |
|
| Trends and predictors of hospitalization, readmissions and length of stay in ambulatory patients with heart failure. |
|
| Use of potassium-binder patiromer for up-titration of renin-angiotensin-aldosterone system inhibition therapy in a patient with chronic heart failure and reduced ejection fraction followed in a multidisciplinary integrated chronic care management pr |
|
| Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions |
|
| Vasopressina, un nou biomarcador en insuficiència cardíaca. |
|
